[go: up one dir, main page]

AR078736A1 - Una solucion de droga de taxanos que comprende un regulador de ph y su metodo de preparacion - Google Patents

Una solucion de droga de taxanos que comprende un regulador de ph y su metodo de preparacion

Info

Publication number
AR078736A1
AR078736A1 ARP100103880A ARP100103880A AR078736A1 AR 078736 A1 AR078736 A1 AR 078736A1 AR P100103880 A ARP100103880 A AR P100103880A AR P100103880 A ARP100103880 A AR P100103880A AR 078736 A1 AR078736 A1 AR 078736A1
Authority
AR
Argentina
Prior art keywords
drug solution
emulsion
regulator
preparation
taxane drug
Prior art date
Application number
ARP100103880A
Other languages
English (en)
Inventor
Jialiang Zhang
Jianming Chen
Baoan Gao
Li Deng
Qiuxia Yang
Jing Sun
Peng Gu
Yingying Zhang
Wei Liu
Original Assignee
Tianjin Tasly Group Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=43899845&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=AR078736(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Tianjin Tasly Group Co Ltd filed Critical Tianjin Tasly Group Co Ltd
Publication of AR078736A1 publication Critical patent/AR078736A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/337—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having four-membered rings, e.g. taxol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Dermatology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

Una solucion de droga de taxano (como por ejemplo, paclitaxel o docetaxel) que comprende un regulador de pH (como por ejemplo: ácido cítrico, láctico, hálico, CIH, acético, fosforico y tartárico y un solvente), método de preparacion y su uso en combinacion con una emulsion. Cuando se utiliza en clínica, la solucion de droga es dispersada en la emulsion y agitada bien, para goteo intravenoso. lnesperadamente, la adicion del regulador de pH prolonga el tiempo de estabiIidad de las drogas dispersadas en la emulsion. Al mismo tiempo, se ha superado el problema del aceite flotante en la superficie de la dispersion mejorando de este modo su seguridad y efectividad en clínica. Más aun, la presente, describe además un método para preparar la solucion de droga de taxanos, una composicion que comprende la solucion de droga de taxanos y una emulsion, y un kit que comprende la solucion de droga de taxanos y una emulsion.
ARP100103880A 2009-10-23 2010-10-22 Una solucion de droga de taxanos que comprende un regulador de ph y su metodo de preparacion AR078736A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN2009100709318A CN102038635A (zh) 2009-10-23 2009-10-23 一种含有pH值调节剂的紫杉烷类药物溶液及其制备方法

Publications (1)

Publication Number Publication Date
AR078736A1 true AR078736A1 (es) 2011-11-30

Family

ID=43899845

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP100103880A AR078736A1 (es) 2009-10-23 2010-10-22 Una solucion de droga de taxanos que comprende un regulador de ph y su metodo de preparacion

Country Status (10)

Country Link
US (1) US9241922B2 (es)
EP (1) EP2491919B2 (es)
JP (1) JP5847722B2 (es)
KR (1) KR101722398B1 (es)
CN (2) CN102038635A (es)
AR (1) AR078736A1 (es)
AU (1) AU2010310258B2 (es)
CA (1) CA2765748C (es)
PL (1) PL2491919T5 (es)
WO (1) WO2011047637A1 (es)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2205215A2 (en) * 2007-10-01 2010-07-14 Intas Pharmaceuticals Limited Docetaxel injectable composition, being absolutely free of ethanol
JP5824511B2 (ja) 2010-05-03 2015-11-25 テイコク ファーマ ユーエスエー インコーポレーテッド 非水タキサンプロエマルジョン配合物ならびにそれを調製および使用する方法
CN101926757B (zh) * 2010-09-01 2013-01-02 北京大学 一种难溶性药物的液体组合物及其制备方法
US8842114B1 (en) 2011-04-29 2014-09-23 Nvidia Corporation System, method, and computer program product for adjusting a depth of displayed objects within a region of a display
JP2013194009A (ja) * 2012-03-21 2013-09-30 Nipro Corp ドセタキセル製剤
JO3685B1 (ar) 2012-10-01 2020-08-27 Teikoku Pharma Usa Inc صيغ التشتيت الجسيمي للتاكسين غير المائي وطرق استخدامها
JP6076744B2 (ja) * 2013-01-04 2017-02-08 ナガセ医薬品株式会社 ドセタキセル含有医薬組成物
JP6292267B2 (ja) * 2016-09-13 2018-03-14 ニプロ株式会社 ドセタキセル製剤
JP2018115178A (ja) * 2018-03-15 2018-07-26 ニプロ株式会社 ドセタキセル製剤
CN111153535B (zh) * 2020-01-19 2022-03-25 武汉市新华印刷有限责任公司 一种显影机冲版废水处理系统

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2678833B1 (fr) 1991-07-08 1995-04-07 Rhone Poulenc Rorer Sa Nouvelles compositions pharmaceutiques a base de derives de la classe des taxanes.
US5877205A (en) * 1996-06-28 1999-03-02 Board Of Regents, The University Of Texas System Parenteral paclitaxel in a stable non-toxic formulation
US7030155B2 (en) * 1998-06-05 2006-04-18 Sonus Pharmaceuticals, Inc. Emulsion vehicle for poorly soluble drugs
US6136846A (en) * 1999-10-25 2000-10-24 Supergen, Inc. Formulation for paclitaxel
GEP20063806B (en) † 2001-12-20 2006-04-25 Bristol Myers Squibb Co Pharmaceutical compositions of orally active taxane derivatives having enhanced bioavailability
EP1558241A2 (en) † 2002-11-08 2005-08-03 Bristol-Myers Squibb Company Pharmaceutical compositions and methods of using taxane derivatives
CN1535679A (zh) * 2003-04-04 2004-10-13 齐鲁制药厂 含有紫杉醇类物质的药物组合物及其制备方法
WO2005095462A1 (en) * 2004-03-31 2005-10-13 Showa Denko K.K. Moisture retention polymer compound
US7846970B2 (en) * 2004-09-24 2010-12-07 Showa Denko K.K. Hydroxycitric acid derivatives and skin external preparations containing the same
US8557861B2 (en) 2004-09-28 2013-10-15 Mast Therapeutics, Inc. Low oil emulsion compositions for delivering taxoids and other insoluble drugs
JP4929158B2 (ja) * 2005-03-14 2012-05-09 株式会社大塚製薬工場 難水溶性薬物を含有する医薬組成物
EP2308467A3 (en) * 2005-06-17 2011-06-22 Hospira Australia Pty Ltd Liquid pharmaceutical formulations of docetaxel
JP2007032374A (ja) † 2005-07-25 2007-02-08 Usui Kokusai Sangyo Kaisha Ltd フューエルデリバリパイプ
CN101023940A (zh) * 2006-02-20 2007-08-29 郝守祝 一种紫杉烷类化合物的药用组合物、制备方法及用途
US7670997B2 (en) * 2006-06-08 2010-03-02 Bausch & Lomb Incorporated Ophthalmic compositions comprising a branched, glycerol monoalkyl compound and a fatty acid monoester
CN101244053B (zh) * 2007-02-16 2010-12-08 石药集团中奇制药技术（石家庄）有限公司 以多西他赛为主组分的新的分散体系
CN101677987A (zh) 2007-06-22 2010-03-24 赛多斯有限责任公司 不含吐温80的多西他赛的增溶制剂
EP2205215A2 (en) * 2007-10-01 2010-07-14 Intas Pharmaceuticals Limited Docetaxel injectable composition, being absolutely free of ethanol
CN101288642B (zh) * 2007-11-07 2011-04-27 天津天士力集团有限公司 一种紫杉烷类药物静脉给药制剂及其制备方法
UA100543C2 (ru) * 2007-12-24 2013-01-10 Сан Фарма Адвансед Ресерч Компани Лимитед Нанодисперсия, включающая наночастицы, которые содержат производное таксана

Also Published As

Publication number Publication date
AU2010310258B2 (en) 2013-09-19
PL2491919T3 (pl) 2017-08-31
CA2765748A1 (en) 2011-04-28
CN102448441A (zh) 2012-05-09
US20120157517A1 (en) 2012-06-21
CA2765748C (en) 2016-10-25
CN102038635A (zh) 2011-05-04
EP2491919A1 (en) 2012-08-29
EP2491919B1 (en) 2016-05-11
JP5847722B2 (ja) 2016-01-27
PL2491919T5 (pl) 2019-12-31
CN102448441B (zh) 2014-09-17
EP2491919A4 (en) 2013-09-18
HK1164708A1 (en) 2012-09-28
JP2013508312A (ja) 2013-03-07
AU2010310258A1 (en) 2012-01-19
US9241922B2 (en) 2016-01-26
KR20120087902A (ko) 2012-08-07
EP2491919B2 (en) 2019-06-26
WO2011047637A1 (zh) 2011-04-28
KR101722398B1 (ko) 2017-05-17

Similar Documents

Publication Publication Date Title
AR078736A1 (es) Una solucion de droga de taxanos que comprende un regulador de ph y su metodo de preparacion
BRPI0615292A8 (pt) composições e métodos para preparação de fármacos de má solubilidade em água com estabilidade aumentada
BR112015005940A2 (pt) processo para a preparação de nanopartículas terapêuticas
WO2017049083A3 (en) Delivery of drug nanoparticles and methods of use thereof
EP4342537A3 (en) Semifluorinated alkane compositions
MX374694B (es) USO DE 1-CLORO-4-(ß-D-GLUCOPIRANOS-1-IL)-2-[4-((S)-TETRAHIDROFURAN-3-ILOXI)-BENCIL]-BENCENO EN COMBINACIÓN CON INSULINA PARA REDUCIR LA DOSIS DE INSULINA Y PARA MEJORAR EL CONTROL GLUCÉMICO EN PACIENTES CON DIABETES MELLITUS.
ES2543957T3 (es) Nueva composición farmacéutica para el tratamiento de infecciones fúngicas
BRPI0707302B8 (pt) compostos de cianoisoquinolina que atuam no dano tecidual associado com isquemia, hipóxia e anemia, bem como composição farmacêutica que os compreende
EA202091999A2 (ru) Применение ингибиторов dpp iv
EA201390612A1 (ru) Биоразлагаемая композиция для доставки лекарственного средства
BR112012010995A2 (pt) revestimentos e métodos de revestimento de agulhas cirúrgicas
BR112014013111A2 (pt) composição dental autoadesiva de componente único, processo de produção e utilização do mesmo
BRPI0915439B8 (pt) composição de gel tópica, bem como uso de um agente ativo para tratamento de ceratose actínica em combinação com um agente ceratoliticamente ativo para preparação da referida composição
BR112015017246A8 (pt) composição farmacêutica aquosa, seu uso e seringa
PA8794401A1 (es) Acidos 6-fenilnicotinicos sustituidos y su uso
AR071120A1 (es) Derivados de diosmetina, su procedimiento de preparacion, las composiciones farmaceuticas que los contienen y su uso en el tratamiento de las enfermedades venosas cronicas.
CO6410278A2 (es) Disoluciones pediátricas que continen un beta-bloqueante
BR112014011868A2 (pt) composições corantes poliméricas e métodos de uso
BR112014003071A2 (pt) tratamento de doença vascular periférica com o uso de células derivadas do tecido do cordão umbilical
DOP2007000043A (es) Derivados de cromanol sustituidos y su uso
EA201401231A1 (ru) Фармацевтические комбинации, предназначенные для лечения метаболических нарушений
BR112016002342A2 (pt) Microesfera entecavir, método para preparação de uma microesfera entecavir, e, composição farmacêutica
BR112012010994A2 (pt) revestimentos e métodos de revestimento de agulhas cirúrgicas
ES2673406T3 (es) Alfa-derivados de ácidos grasos cis-monoinsaturados para uso como medicamentos en el tratamiento de la diabetes
CO2017005201A2 (es) Ácido benzóico, derivados de ácido benzóico y conjugados heteroarilcarboxílico de la oxicodona

Legal Events

Date Code Title Description
FC Refusal